Home

Top Jobs
Project Engineer
Energy Services Engineer
Energy Manager
Energy Program Director
Energy Engineer / Staff Engineer
Program Manager – Industrial Products & Systems
Senior Engineer
Energy Manager
Energy Engineer - Pittsburgh
Energy Engineer
Submit a Position
Find a Position

Upcoming Events
Best Practices & Financial Risk
Houston, TX,
4/25/17 - 4/26/17
Argus Asian Petroleum Coke 2017
TBA, Mumbai, India,
4/25/17 - 4/27/17
MENA New Energy (MENASol) 2017
??Hyatt Regency Dubai, Deira, P.O. Box 5588, Dubai, United Arab Emirates,
4/25/17 - 4/26/17
MENA New Energy (MENASol) 2017
Hyatt Regency Dubai, Deira, P.O. Box 5588, Dubai, United Arab Emirates,
4/25/17 - 4/26/17
ConMin West Africa 2017
Abuja International Conference Centre, Central Area, Area 11, 900 Herbert Macaulay Way, Abuja, 900001, Nigeria,
4/25/17 - 4/27/17
Submit an Event
View All Events


Sain Featured Employer

Open Therapeutics LLC Buys Majority Stake of Pilus Energy Subsidiary from Tauriga Sciences, Inc.

 

Follow energycareer on Twitter

Sign-Up for Free Energy, Facility, Power Newsletter (EFPN) newsletter

 

 

 

Open Therapeutics™ has purchased an 80 percent majority stake in Tauriga Sciences, Inc.’s wholly-owned subsidiary, Pilus Energy LLC, according to Jerome Hamilton, CEO of Open Therapeutics. Tauriga Sciences, Inc. is engaged in building businesses in the life sciences space. Following its acquisition, Open Therapeutics plans to continue the development of Pilus Energy’s proprietary technology with the goal of commercialization, says Hamilton. The technology involves removing bacteria from water and converting the bacteria into energy. Hamilton says that Open Therapeutics is looking at the agreement with Tauriga as a means of creating the potential for Pilus Energy to become successful in commercializing its technology:

“We have a vision to continue that process for Pilus Energy, and Tauriga’s management will be helpful in realizing those mutually beneficial efforts,” says Hamilton. He adds that the acquisition will create synergy with Open Therapeutics, which launches its new platform in late January or early February 2017 to enable bio researchers around the world to openly exchange information without charge, based upon open source collaboration, that can lead to acceleration of research results. Researchers will then be able publish their findings in prestigious publications around the world.

Return Home

 

Follow energycareer on Twitter